Roche offers $5.7 billion to buy gene firm Illumina

(Reuters) - Roche Holding AG is offering $5.7 billion in cash to buy U.S. gene sequencing company Illumina Inc in an unfriendly takeover bid that marks a major play by the Swiss drugmaker into the gene technology field. Gene sequencing is central ...